We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
250 hedge funds and large institutions have $5.66B invested in Fate Therapeutics in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 96 increasing their positions, 73 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
78% more call options, than puts
Call options by funds: $18.9M | Put options by funds: $10.6M
32% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 73
0.92% more ownership
Funds ownership: 100.55% → 101.46% (+0.92%)
0% less capital invested
Capital invested by funds: $5.67B → $5.66B (-$8.82M)
6% less funds holding
Funds holding: 265 → 250 (-15)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
24% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 51
Holders
250
Holders Change
-15
Holders Change %
-5.66%
% of All Funds
3.85%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.14%
New
39
Increased
96
Reduced
73
Closed
51
Calls
$18.9M
Puts
$10.6M
Net Calls
+$8.24M
Net Calls Change
+$24.8M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$185M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$43.2M |
| 3 |
Morgan Stanley
New York
|
+$32.4M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$30.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$28.3M |
